BioLineRx Ltd. (TLV: BLRX)
Israel
· Delayed Price · Currency is ILS · Price in ILA
12.40
0.00 (0.00%)
Nov 17, 2024, 3:49 PM IDT
BioLineRx Employees
BioLineRx had 79 employees as of December 31, 2023. The number of employees increased by 30 or 61.22% compared to the previous year.
Employees
79
Change (1Y)
30
Growth (1Y)
61.22%
Revenue / Employee
812.50K ILS
Profits / Employee
-1.44M ILS
Market Cap
151.18M
Employees Chart
BioLineRx News
- 4 weeks ago - BioLineRx receives USPTO allowance of new composition of matter patent on motixafortide - Seeking Alpha
- 4 weeks ago - BioLineRx Announces USPTO Allowance of New Composition of Matter Patent on Motixafortide - PRNewsWire
- 2 months ago - BioLineRx Launches 'Mobilization Matters': A Digital Resource for People with Multiple Myeloma Preparing for Stem Cell Collection - PRNewsWire
- 3 months ago - BioLineRx Ltd. (BLRX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioLineRx GAAP EPS of $0.00, revenue of $5.39M - Seeking Alpha
- 3 months ago - BioLineRx Reports Second Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates - PRNewsWire
- 3 months ago - biolinerx Q2 Earnings Preview - Seeking Alpha
- 3 months ago - BioLineRx to Report Second Quarter 2024 Results on August 15, 2024 - PRNewsWire